Mednow Inc.
MDNWF · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | |
|---|---|---|---|
| Revenue | $17 | $0 | $0 |
| % Growth | 3,919% | – | – |
| Cost of Goods Sold | $14 | $0 | $0 |
| Gross Profit | $3 | $0 | $0 |
| % Margin | 16.7% | 100% | – |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $20 | $8 | $0 |
| SG&A Expenses | $23 | $9 | $0 |
| Sales & Mktg Exp. | $3 | $1 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 |
| Operating Expenses | $22 | $9 | $0 |
| Operating Income | -$20 | -$9 | -$0 |
| % Margin | -118.3% | -2,124.9% | – |
| Other Income/Exp. Net | -$10 | -$0 | $0 |
| Pre-Tax Income | -$30 | -$9 | -$0 |
| Tax Expense | -$1 | $0 | $0 |
| Net Income | -$29 | -$9 | -$0 |
| % Margin | -177.2% | -2,162.8% | – |
| EPS | -1.37 | -0.49 | -0.022 |
| % Growth | -179.6% | -2,158.1% | – |
| EPS Diluted | -1.37 | -0.49 | -0.022 |
| Weighted Avg Shares Out | 22 | 18 | 22 |
| Weighted Avg Shares Out Dil | 22 | 18 | 22 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 |
| EBITDA | -$21 | -$9 | -$0 |
| % Margin | -125.4% | -2,165.5% | – |